GSK Investigational Site

Farkasgyepű 8582

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed